Fol. Biol. 2003, 49, 63-68
https://doi.org/10.14712/fb2003049020063
Pretreatment with Interleukin-2 Modulates Perioperative Immunodysfunction in Patients with Renal Cell Carcinoma
References
1. 1997) Postoperative immune function varies inversely with the degree of surgical trauma in a murine model. Surg. Endosc. 11, 427-430.
< , J. D., Bessler, M., Whelan, R. L., Trokel, M., Laird, D. A., Terry, M. B., Treat, M. R. (https://doi.org/10.1007/s004649900383>
2. American Cancer Society (2000) American Cancer Society's Guide to Complementary and Alternative Cancer Methods. American Cancer Society, Atlanta.
3. 2000) Detection of circulating cancer cells with von Hippel-Lindau gene mutation in peripheral blood of patients with renal cell carcinoma. Clin. Cancer. Res. 6, 3817-3822.
, S., Okuda, H., Chikazawa, M., Tanimura, M., Sugita, O., Yamamoto, Y., Nakamura, S., Moriyama, M., Shuin, T. (
4. 1996) Interleukin-6 in the injured patient - marker of injury or mediator of inflammation? Ann. Surg. 224, 647-664.
< , W. L., Moore, E. E., Moore, F. A., Peterson, V. M. (https://doi.org/10.1097/00000658-199611000-00009>
5. 2001) Detection and enrichment of disseminated renal carcinoma cells from peripheral blood by immunomagnetic cell separation. Int. J. Cancer 92, 577-582.
< , U., Taubert, H., Riemann, D., Rebmann, U., Heynemann, H., Meye, A. (https://doi.org/10.1002/ijc.1217>
6. 1995) Preoperative interleukin-2 immunotherapy induces eosinophilic infiltration in colorectal neoplastic stroma. Pathologica 87, 135-138.
, G., Brivio, F., Brenna, A., Fumagalli, L., Perego, P., Brivio, O., Uggeri, F., Lavorato, F., Bratina, G. (
7. 2001) Complex perioperative immunodysfunction in patients with renal cell carcinoma. J. Urol. 166, 831-836.
< , M., Ittenson, A., Philipp, C., Röhl, F.-W., Ansorge, S., Allhoff, E. P. (https://doi.org/10.1016/S0022-5347(05)65846-6>
8. 2002) Pretreatment with interleukin-2 (IL-2) attenuates perioperative immunodysfunction in patients with renal cell carcinoma. Eur. Urol. 41, 458-468.
< , M., Ittenson, A., Schierbaum, K. F., Röhl, F.-W., Ansorge, S., Allhoff, E. P. (https://doi.org/10.1016/S0302-2838(02)00031-3>
9. Brivio, F., Brivio, O., Lissoni, P., Emanuelli, G., Girlando, M., Uggeri, F. (1997) Presurgical neuroimmunotherapy with melatonin and interleukin-2 in cancer patients. In: Therapeutic Potential of Melatonin. Front. Horm. Res., eds. Maestroni, G. J. M., Conti, A., Reiter, R. J., pp. 137-148, Karger, Basel.
10. 1996) Preoperative interleukin-2 subcutaneous immunotherapy may prolong the survival time in advanced colorectal cancer patients. Oncology 53, 263-268.
< , F., Lissoni, P., Alderi, G., Barni, S., Lavorato, F., Fumagalli, L. (https://doi.org/10.1159/000227571>
11. 1993) Effects of a preoperative course of interleukin-2 on surgical and immunobiological variables in patients with colorectal cancer: a phase 2 study. Eur. J. Surg. 159, 43-47.
, F., Lissoni, P., Barni, S., Tancini, G., Ardizzoia, A., Erba, L., Alderi, G., Nociti, V. (
12. 1992) Effects of a preoperative therapy with interleukin-2 on surgeryinduced lymphocytopenia in cancer patients. Oncology 49, 215-218.
< , F., Lissoni, P., Tisi, E., Erba, L., Barni, S., Tancini, G., Rescaldani, R., Alderi, G., Nociti, V. (https://doi.org/10.1159/000227041>
13. 1998) Effects of anaesthesia based on high versus low doses of opioids on the cytokine and acute-phase protein responses in patients undergoing cardiac surgery. Acta Anaesthesiol. Scand. 42, 63-70.
< , V., Tønnesen, E., Sørensen, I. J., Bilfinger, T. V., Sanchez, R. G., Stefano, G. B. (https://doi.org/10.1111/j.1399-6576.1998.tb05082.x>
14. 1993) Improved sandwich enzyme-linked immunosorbent assays for transforming growth factor fl1. J. Immunol. Methods 158, 17-25.
< , D. (https://doi.org/10.1016/0022-1759(93)90254-5>
15. 1995) Modulation of the cytokine and acute-phase response to major surgery by recombinant interleukin-2. Br. J. Surg. 82, 86-90.
< , D. J., Heys, S. D., Simpson, W., Broom, J., McMillan, D. N., Eremin, O. (https://doi.org/10.1002/bjs.1800820130>
16. 1999) Back to the future - the role of complementary medicine in urology. J. Urol. 162, 411-420.
< , W. R. (https://doi.org/10.1016/S0022-5347(05)68573-4>
17. 2000) Why is urological laparoscopy minimally invasive? Eur. Urol. 37, 241-250.
< , P., Doehn, C., Seyfarth, M., Jocham, D. (https://doi.org/10.1159/000052351>
18. 1997) The choice of anesthetic maintenance technique influences the antiinflammatory cytokine response to abdominal surgery. Anesth. Analg. 85, 1394-1398.
< , H. E., Armstrong, M. A., Carabine, U., McMurray, T. J. (https://doi.org/10.1213/00000539-199712000-00039>
19. 2000) Cellmediated immune response is better preserved by laparoscopy than laparotomy. Surgery 127, 65-71.
< , C. A., Mendoza-Sagaon, M., Talamini, M. A., Ahmad, S. A., Pegoli, W. J., Paidas, C. N. (https://doi.org/10.1067/msy.2000.101152>
20. 1990) Radical extensive surgery for renal cell carcinoma: longterm results and prognostic factors. J. Urol. 143, 468-474.
< , L., Giberti, C., Martorana, G., Rovida, S. (https://doi.org/10.1016/S0022-5347(17)39992-5>
21. 1997) Modulation of immune response by blood transfusion: evidence for a differential effect of allogeneic and autologous blood in colorectal cancer surgery. Shock 8, 402-408.
< , M. M., Fraunberger, P., Delanoff, C., Stets, R., Allgayer, H., Strohlein, M. A., Tarabichi, A., Faist, E., Jauch, K. W., Schildberg, F. W. (https://doi.org/10.1097/00024382-199712000-00002>
22. 1997) Distinct mechanisms of immunosuppression as a consequence of major surgery. Infect. Immun. 65, 2283-2291.
< , T., Hecker, H., Heeg, K., Heidecke, C.-D., Bartels, H., Barthlen, W., Wagner, H., Siewert, J. R., Holzmann, B. (https://doi.org/10.1128/iai.65.6.2283-2291.1997>
23. 1991) What are the benefits of extended dissection of the regional lymph nodes in the therapy of renal cell carcinoma? J. Urol. 146, 1224-1227.
< , A., Schrott, K. M., Schott, G., Sigel, A. (https://doi.org/10.1016/S0022-5347(17)38052-7>
24. 1997) IL-6 and soluble IL-6 receptor levels change differently after surgery both in the blood and in the operative field. Cytokine 9, 447-447.
< , S., Sakamoto, K., Ishiko, T., Kamohara, H., Ogawa, M. (https://doi.org/10.1006/cyto.1996.0187>
25. 1969) Occurrence and localization of lymph node metastases in renal carcinoma. Scand. J. Urol. Nephrol. 3, 129-133.
< , L., Rosencrantz, M., Seeman, T., Wahlqvist, L., Åhrén, C. (https://doi.org/10.3109/00365596909135393>
26. 1999) Effects of anaesthesia on the human immune system. Hosp. Med. 60, 658-663.
< , J. D. (https://doi.org/10.12968/hosp.1999.60.9.1198>
27. 1998) Blood transfusion and post-operative serum interleukin-6 levels in colorectal cancer patients. Hepatogastroenterology 45, 1011-1013.
, N., Suzuki, H. (
28. 1998) Interleukin-10 production during and after upper abdominal surgery. J. Clin. Anesth. 10, 184-188.
< , M., Honda, I., Suzuki, H., Murakami, M., Matsukawa, S., Hashimoto, Y. (https://doi.org/10.1016/S0952-8180(97)00264-X>
29. 1992) Interleukin-6 and renal cell cancer: production, regulation, and growth effects. Cancer Immunol. Immunother. 35, 97-105.
< , A. S., Armstrong, C., Bochner, B., Shimabukuro, T., Tso, C.-L., DeKernion, J. B., Belldegrun, A. (https://doi.org/10.1007/BF01741856>
30. 1998) Prospective randomized study of stress and immune response after laparoscopic vs conventional colonic resection. Surg. Endosc. 12, 963-967.
< , C., Wunsch, A., Bay, F., Windeler, J., Glaser, F., Herfarth, C. (https://doi.org/10.1007/s004649900757>
31. 2000) Lymphocyte responses following open and minimally invasive thoracic surgery. Eur. J. Clin. Invest. 30, 230-238.
< , H. A., Craig, S. R., Yap, P. L., Walker, W. S. (https://doi.org/10.1046/j.1365-2362.2000.00622.x>
32. 2000) Dendritic cell-based immunotherapy of prostate cancer: immune monitoring of a phase II clinical trial. Cancer Res. 60, 829-833.
, P., Jones, L., Bader, R., Murphy, G., Salgaller, M. (
33. 1998) Phase-II randomized study of pre-operative IL-2 administration in operable NSCLC. Lung Cancer 20, 191-202.
< , A., Morandini, G., Ortolani, R., Fumagalli, L. (https://doi.org/10.1016/S0169-5002(98)00024-5>
34. 1999) The detection of renal carcinoma cells in the peripheral blood with an enhanced reverse transcriptase-polymerase chain reaction assay for MN/CA9. Cancer 86, 492-497.
< , J. M., Buttyan, R., Bander, N. H., de la Taille, A., Stifelman, M. D., Emanuel, E. R., Bagiella, E., Rubin, M. A., Katz, A. E., Olsson, C. A., Sawczuk, I. S. (https://doi.org/10.1002/(SICI)1097-0142(19990801)86:3<492::AID-CNCR18>3.0.CO;2-R>
35. 1989) Interleukin-6 (IL-6) functions as an autocrine growth factor in renal cell carcinomas. FEBS Lett. 250, 607-610.
< , S., Iwano, M., Miki, Y., Yamamoto, M., Tang, B., Yokokawa, K., Sonoda, T., Hirano, T., Kishimoto, T. (https://doi.org/10.1016/0014-5793(89)80805-1>
36. 1992) Perioperative immunotherapy with recombinant interleukin 2 in patients undergoing surgery for colorectal cancer. Cancer Res. 52, 5765-5769.
, P. H., Ramsden, C. W., Ward, U., Sedman, P. C., Primrose, J. N. (
37. 1993) Peri-operative modulation of cellular immunity in patients with colorectal cancer. Clin. Exp. Immunol. 94, 4-10.
< , P. H., Ramsden, C. W., Ward, U., Trejdosiewicz, L. K., Ambrose, N. S., Primrose, J. N. (https://doi.org/10.1111/j.1365-2249.1993.tb05968.x>
38. 2000) Suppression of cellular immunity by surgical stress. Surgery 127, 329-336.
< , K., Hirai, M., Katsube, T., Murayama, M., Hamaguchi, K., Shimakawa, T., Naritake, Y., Hosokawa, T., Kajiwara, T. (https://doi.org/10.1067/msy.2000.103498>
39. 1992) Effects of major and minor surgery on plasma glutamine and cytokine levels. Arch. Surg. 127, 1237-1240.
< , M., Baigrie, R. J., Lamont, P. M., Morris, P. J., Newsholme, E. A. (https://doi.org/10.1001/archsurg.1992.01420100099017>
40. 2000) The role of different subsets of T regulatory cells in controlling autoimmunity. Curr. Opin. Immunol. 12, 676-683.
< , M.-G., Levings, M. K. (https://doi.org/10.1016/S0952-7915(00)00162-X>
41. 2001) Differentiation of T regulatory cells by immature dendritic cells. J. Exp. Med. 193, F5-F9.
< , M.-G., Levings, M. K., Traversari, C. (https://doi.org/10.1084/jem.193.2.F5>
42. SAS Institute Inc. (1994) SAS/STAT User's Guide, Version 6; SAS Institute, Cary, North Carolina.
43. 1991) Renal cell carcinoma: vena caval invasion and prognostic factors. Eur. Urol. 19, 284-290.
< , P., Zudaire, J. J., Robles, J. E., Rosell, D., Aguera, L., De Castro, F., Isa, W., Berián, J. M. (https://doi.org/10.1159/000473644>
44. 1997) Cytokines in anaesthesia. Br. J. Anaesth. 78, 201-219.
< , P., Hall, G. M. (https://doi.org/10.1093/bja/78.2.201>
45. 1999) What is the role of interleukin 10 in polymicrobial sepsis: anti-inflammatory agent or immunosuppressant? Surgery 126, 378-383.
< , G. Y., Chung, C.-S., Chaudry, I. H., Ayala, A. (https://doi.org/10.1016/S0039-6060(99)70180-7>
46. 1998) The effect of peritoneal air exposure on postoperative tumour growth. Surg. Endosc. 12, 348-350.
< , J. C., Lee, S. W., Bessler, M., Allendorf, J. D., Whelan, R. L. (https://doi.org/10.1007/s004649900668>
47. 1999) The influence of surgery and anesthesia on lymphocyte functions in breast cancer patients: in vitro effects of indomethacin. Neoplasma 46, 54-60.
, N., Vuckovic-Dekic, L., Radomirovic, S., Juranic, Z., Jovanovic, N. (
48. 1999) IL-10 is a major mediator of sepsis-induced impairment in lung antibacterial host defense. J. Immunol. 162, 392-399.
< , M. L., Hogaboam, C. M., Kunkel, S. L., Lukacs, N. W., Strieter, R. M., Standiford, T. J. (https://doi.org/10.4049/jimmunol.162.1.392>
49. 1991) Enhanced expression of interleukin-6 in primary human renal cell carcinomas. J. Natl. Cancer Inst. 83, 1668-1672.
< , J., Kaneko, Y., Fukumoto, M., Fukatsu, A., Hirano, T., Fukuyama, H., Nakayama, H., Fujita, J., Yoshida, O. (https://doi.org/10.1093/jnci/83.22.1668>
50. 1995) Inhibitory effect of dexamethasone and progesterone in vitro on proliferation of human renal cell carcinomas and effects on expression of interleukin-6 or interleukin-6 receptor. J. Urol. 153, 858-862.
< , J., Kaneko, Y., Okumura, K., Yoshida, O., Nakayama, H., Fujita, J. (https://doi.org/10.1016/S0022-5347(01)67736-X>
51. 1996) Biology of metastasis and its clinical implications: renal-cell cancer. World J. Urol. 14, 175-181.
< , J. C., Klein, E. A. (https://doi.org/10.1007/BF00186897>
52. World Health Organization (1979) WHO Handbook for Reporting Results of Cancer Treatment, World Health Organization, Geneva.